Ultrasep ES Pharm-RP8 is a silica-based HPLC column with a pharmaceutical-grade C8 bonded phase. Compared to C18 phases, the shorter C8 chains provide reduced hydrophobic retention, enabling faster elution and improved peak resolution for moderately hydrophobic analytes. This makes Pharm-RP8 a versatile option for pharmaceutical analysis where balanced selectivity and shorter run times are critical.
Engineered with robust bonding chemistry, Ultrasep ES Pharm-RP8 delivers reproducible results, sharp peak shapes, and long column lifetimes. It is especially suitable for pharmaceutical quality control, impurity profiling, and stability studies.
Ultrasep ES Pharm-RP8 provides pharmaceutical-grade performance with balanced hydrophobicity – the dependable choice for versatile reversed-phase HPLC separations.
Silica-based stationary phase with C8 bonded chemistry
Balanced hydrophobic retention for faster separations
Enhanced resolution for moderately hydrophobic compounds
Robust bonding for reproducibility and long lifetime
Available particle size: 5 µm
Pharmaceutical quality control and impurity profiling
Stability-indicating assays and degradation studies
Faster separations compared to C18 phases
Method development for moderately hydrophobic drugs
| Particle Size |
|
|---|---|
| Pore Size | 100 Å |
| Particle Type | |
| Separation Mode | |
| USP Code | |
| pH Range | 2 - 8 |
| Phase | Material Number |
|---|---|
| Ultrasep ES Pharm-RP8, 5 µm | u15.p8. |